Avalo Therapeutics Inc (AVTX) financials · rev $59.0K
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Avalo Therapeutics Inc (AVTX) rev $59.0K.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $59.0K | $441.0K |
| Operating Income | -$72.9M | -$68.5M |
| Net Income | -$78.3M | -$35.1M |
| EPS (Diluted) | -$5.84 | -$20.91 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $116.5M | $150.7M |
| Current Assets | $105.3M | $138.9M |
| Cash & Equivalents | $15.9M | $134.5M |
| Total Liabilities | $33.4M | $17.7M |
| Current Liabilities | $12.9M | $6.96M |
| Shareholders' Equity | $83.0M | $133.0M |
| Retained Earnings | -$448.5M | -$370.3M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$51.5M | -$49.1M |
| CapEx | N/A | N/A |
| Investing Cash Flow | -$81.7M | $356.0K |
| Financing Cash Flow | $14.6M | $175.8M |
| Net Change in Cash | -$118.6M | $127.1M |
| Free Cash Flow | N/A | -$49.1M |
FAQ
What is AVTX P/E and revenue?
Avalo Therapeutics Inc (AVTX) rev $59.0K.
What is AVTX revenue?
Avalo Therapeutics Inc last cached revenue is $59.0K (FY2025).
Is AVTX profitable?
Avalo Therapeutics Inc last cached net income is -$78.3M (FY2025).
What are AVTX total assets?
Avalo Therapeutics Inc last cached total assets are $116.5M (FY2025).
What is AVTX free cash flow?
No cached cash-flow row for AVTX yet.
Not investment advice. Cached statements, not a live tape.